Market revenue in 2024 | USD 16.4 million |
Market revenue in 2030 | USD 26.1 million |
Growth rate | 8.2% (CAGR from 2025 to 2030) |
Largest segment | Allograft |
Fastest growing segment | Synthetic |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allograft, Synthetic |
Key market players worldwide | DePuy Synthes, Baxter International Inc, NuVasive, Smith & Nephew PLC, Medtronic PLC, Orthofix Medical Inc, Zimmer Biomet Holdings Inc, Geistlich Pharma, Stryker Corp, AlloSource, TBF, OST Laboratoires, Biobank |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bone grafts and substitutes market will help companies and investors design strategic landscapes.
Allograft was the largest segment with a revenue share of 65.85% in 2024. Horizon Databook has segmented the Sweden bone grafts and substitutes market based on allograft, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
Growing cases of joint replacement procedure in Sweden is propelling market growth. According to the Bone & Joint report, by the end of 2021, 3.2% of the population in Sweden had undergone at least one replacement of the hip or knee.
Among individuals aged 80, the occurrence of any joint replacement was 17.5%. The rates of both hip and knee replacements were consistently higher among women across all age groups. Specifically for knee replacements, the prevalence reached its highest point at age 89 (9.4%), while the rate of hip replacements steadily rose with age.
Moreover, the presence of various manufacturers in the country is accelerating market growth. In May 2024, the Swedish company, Oss Dsign Catalyst, reported that five thousand patients have received treatment with Oss Dsign AB’s nano synthetic bone graft.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden bone grafts and substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Sweden bone grafts and substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account